Sign Up to like & get
recommendations!
0
Published in 2021 at "International Journal of Clinical Practice"
DOI: 10.1111/ijcp.14705
Abstract: Adding dexrazoxane to the treatment during neoadjuvant/adjuvant anthracycline‐based chemotherapy in patients with breast cancer prevents the development of heart failure. In this study, we investigated whether dexrazoxane has a protective effect on arrhythmia resulting from…
read more here.
Keywords:
patients breast;
neoadjuvant adjuvant;
adjuvant anthracycline;
based chemotherapy ... See more keywords